Ready on paper, stalled on ground: Why the last mile will make or break maternal vaccine rollout
A vaccine can be prequalified, financed and procured, but still fail to reach a woman in her third…
The Price of Protection: Breaking down the cost of maternal RSV vaccines
For RSV, the science has largely done its part, and the remaining obstacle is…
ISSAD 2026: ‘No disease asks for a visa to cross the border’
Kenya takes centre stage in global push to end leading cause of…
Dr Hellen Barsosio: The researcher turning a grandmother’s grief into a generation’s hope
Dr Barsosio grew up in the shadow of eight pregnancies her grandmother…
Dr Angela Koech: One woman, one bacterium, and one question that changed everything
She used to spend her days in delivery rooms, catching babies. Now…
Kenya’s GBS challenge: A vaccine is coming, but will it reach the last mile?
The hardest part of making a vaccine is not the science. It…
GBS and newborn meningitis: Why Kenya’s data tells only part of the story
GBS is hiding in plain sight. The data does not show it.…
Beyond the lab: The race to have GBS vaccines reach every mother, everywhere
For low-income countries, life-saving vaccines often arrive decades late. Scientists are now…
The first 90 days: The slim window to shield newborns from sepsis, pneumonia, meningitis
Carried silently by millions of women, Group B Strep can turn a…
GBS: The hidden bacteria driving maternal sepsis and stillbirths, yet rarely tested
Each year, 134,000 babies are born prematurely in Kenya, which has no…
